MA
ONC

MYDA Advisors’s BeOne Medicines Ltd ONC Stock Holding History

MYDA Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,500
Closed -$384K – 189
2018
Q2 		$384K Buy
+2,500
New +$446K 0.17% 102
2018
Q1 		– Sell
-4,600
Closed -$450K – 188
2017
Q4 		$450K Buy
+4,600
New +$421K 0.2% 96

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MYDA Advisors's ONC Position: Q3 2018 in Review

MYDA Advisors sold out of BeOne Medicines Ltd (ONC) in Q3 2018, closing a stake of 2,500 shares — an estimated $384K sold.

MYDA Advisors first reported a position in ONC in Q4 2017 and held it in 2 quarters. The position peaked at $450K in Q4 2017. 144 funds tracked by Wall St. Rank hold ONC as of Q3 2018.

  • MYDA Advisors reported no remaining BeOne Medicines Ltd position as of Q3 2018 after selling out during the quarter.
  • MYDA Advisors sold 2,500 BeOne Medicines Ltd shares in Q3 2018, an estimated $384K.
  • MYDA Advisors first reported a position in BeOne Medicines Ltd in Q4 2017 and held it in 2 quarters.
  • MYDA Advisors's BeOne Medicines Ltd position peaked at $450K in Q4 2017.
  • 144 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2018.

Based on MYDA Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.